Yunchen focuses on the digital diagnostic platform and smart IoT industrialization in the field of home self-testing. Currently, it is targeting women's reproductive health, particularly for those facing difficulties in conceiving and those seeking optimal pregnancy outcomes. It is a leading brand in digital reproductive health in China. Since its establishment in 2013, Yunchen has been deeply engaged in the Fertility Awareness Method (FAM) medical technology and smart IoT platform. Leveraging the research capabilities of its core team from Tsinghua University and Peking University, it has combined the FAM, which originated in Germany, with real-world data from female users both domestically and internationally. This has led to the development of the iFAM algorithm, which is used by over 6 million users worldwide. The company boasts a physiological cycle database with over a billion female markers and has received professional recognition from dozens of industry users, including Beijing Obstetrics and Gynecology Hospital, Aviation General Hospital, Jinxin Reproductive, Merck China, Wanfu Biology, Mama Network, and others.

YunCheng (孕橙)

YunCheng (孕橙)